Assessment of Cognition and Quality of Life in Non-Hodgkin’s Lymphoma Patients One Year Post-Treatment


An increasing number of patients with cancer are offered chemotherapy given either alone or in combination with radiotherapy, surgery, or both as neo-adjuvant, concomitant, or adjuvant treatment. Cognitive dysfunction is a prevalent side effect of cancer treatments that may persist for years following treatment and has negative impact on quality of life. Thus, the present study was planned to investigate the prevalence of cognitive impairment, assess the quality of life (QOL) and determine the socioeconomic status in NHL patients one year post chemotherapy treatment.

Keywords: Cognitive impairment; Non-hodgkin’s lymphoma; Quality of life; Socioeconomic status

Full Text link:

Journal home page:

PDF link:


Journal accepts original manuscripts in the form of research articles, review articles, Clinical reviews, commentaries, case reports, perspectives and short communications encompassing all aspects of related to Thyroid for publication in open access platform. All the manuscript published are available freely online immediately after publication without any subscription charges or registration.

Submit manuscripts through online link: or as an attachment to below Email Id

Media Contact:
Eliza Grace
Managing Editor
Journal of Clinical Research and Bioethics
What’s App : +1-947-333-4405